中牟田弘道 (Hiromichi Nakamuta) - マイポータル - researchmap

基本情報

所属: 広島国際大学薬学部薬学科薬効解析学教室教授

学位: 薬学博士(大阪大学)

J-GLOBAL ID: 200901035087219166
researchmap会員ID: 1000106923

研究キーワード

2

研究分野

2

学歴

4

MISC

31

The ovariectomized animal model of postmenopausal bone loss

Nippon Rinsho 62(2) 759-763 2004年
Osteoporosis reguires bone-specific statius

Curr. Pharm. Des. 10(21) 2604-2613 2004年
New signaling pathway for parathyroid, hormone and cxclic AMP action on extracellular-regulated kinase and cell proliferation in bone cells

J. Biol. Chem 277, 22191-22200 2002年
New signaling pathway for parathyroid, hormone and cxclic AMP action on extracellular-regulated kinase and cell proliferation in bone cells

J. Biol. Chem 277, 22191-22200 2002年
Incadronate and etidronate accelerate phosphate-primed mineralization of MC4 cells via ERK1/2-Cbfal signaling pathway in a Ras-independent manner: Further involvement of mevalonate-pathway blockade for incadronate

T Fujita, N Izumo, R Fukuyama, T Meguro, C Yasutomi, H Nakamuta, M Koida

JAPANESE JOURNAL OF PHARMACOLOGY 86(1) 86-96 2001年5月
Lipophilic statins can be osteogenic by promoting osteoblastic calcification in a Cbfal-and BMP-2-independent manner

Methods Find. Exp. Clin. Pharmacol 23, 389-394 2001年
Transactivation of care binding factor α1 as a basic mechanism to trigger parathyroid hormone-induced osteogenesis

Jpn. J. Pharmacol 86, 405-416 2001年
Lipophilic statins can be osteogenic by promoting osteoblastic calcification in a Cbfal-and BMP-2-independent manner

Methods Find. Exp. Clin. Pharmacol 23, 389-394 2001年
Transactivation of care binding factor α1 as a basic mechanism to trigger parathyroid hormone-induced osteogenesis

Jpn. J. Pharmacol 86, 405-416 2001年
Phosphate stimulates differentiation and mineralization of chondroprogenitor clone ATDC5

Takashi Fujita, Toru Meguro, Nobuo Izumo, Chigusa Yasutomi, Ryo Fukuyama, Hiromichi Nakamuta, Masao Koida

Jpn. J. Pharmacol 85(3) 278-281 2001年
Phosphate provides an extracellular signal that drives nuclear export of Runx2/Cbfa1 in bone cells

Biochem Biophys Res Commun 280(1) 348-352 2001年
Bone-anabolic effect of salmon calcitonin on glucocorticoid-induced osteopenia in rats

H Furuichi, R Fukuyama, N Izumo, T Fujita, T Kohno, H Nakamuta, M Koida

BIOLOGICAL & PHARMACEUTICAL BULLETIN 23(8) 946-951 2000年8月
Bone anabolic effects of PTH(1-34) and salmon calcitonin in ovariectomy- and ovariectomy-steroid-induced osteopenic rats: A histomorphometric and biomechanical study

T Fukushima, T Nitta, H Furuichi, N Izumo, T Fukuyama, H Nakamuta, M Koida

JAPANESE JOURNAL OF PHARMACOLOGY 82(3) 240-246 2000年3月
Glucocorticoid-induced secondary osteopenia in female rats: A time course study as compared with ovariectomy-induced osteopenia and response to salmon calcitonin

T Nitta, T Fukushima, H Nakamuta, M Koida

JAPANESE JOURNAL OF PHARMACOLOGY 79(3) 379-386 1999年3月
Determination of the bioavailability of intranasal elcatonin in humans : development of a sandwich transfer engyme immunoassay for elcatonin

Journal of Clinical Laboratory Analysis 12 356 1998年
Development of a Highly Sensitive and specific two-site engyme Immunoassay for parathyroid hormone(1-34) : application to pharmacokinetic study on intranasal parathyroid hormone(1-34)in human

Journal of Clinical Laboratory Analysis 12 268 1998年
A sandwich transfer enzyme immunoassay for salmon calcitonin : determination of the bioavailability of intranasol salmon calcitonin in human

Journal of Clinical Caboratory Analysis 11 380 1997年
Plasma level monitoring of nasal salmon calcitonin in rat by a heterogeneous two-site eugyme immunoassay

J. Clin. Lab. Anal. 11 129 1997年
Determinants for calcitonin analog interaction with the calcitonin receptor N-terminus and transmembrane region

Eudocrinology 137(11) 4752 1996年
A noncompetitive enzyme immunoassay (hetero-two-site enzyme immunoassay) for salmon calcitonin : determination of bioavailability of subcutaneous salmon calcitonin and its correlation with the hypocalcemic activity in rats

J. Clin. Lab. Anal. 10 91 1996年

もっとみる

所属学協会

7

共同研究・競争的資金等の研究課題

6